Sona Nanotech Inc stock analysis
Want to see TSE:SONA full AI Analyst Report?
Sona Nanotech Inc (SONA) Stock Price & Analysis
SONA Stock Chart & Stats
- Day’s Range
- CAD 0.28 - CAD 0.29
- 52-Week Range
- CAD 0.26 - CAD 0.61
- Previous Close
- CAD 0.30
- Volume
- N/A
- Average Volume (3M)
- 59.43K
- Market Cap
- CAD 34.38M
- Enterprise Value
- CAD 32.35M
- Total Cash (Recent Filing)
- CAD 17.21K
- Total Debt (Recent Filing)
- CAD 340.16K
- Price to Earnings (P/E)
- ―
- Beta
- 0.88
- Next Earnings
- Mar 01, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Proprietary Diagnostic Technology
The company’s proprietary gold nanorod platform is designed as an alternative to traditional nanoparticles, with potential performance benefits in diagnostic assays. If commercialization succeeds, differentiated sensitivity could support adoption across lateral-flow, immunoassay, and research applications.
Reduced Net Losses
The reduction in net losses indicates meaningful cost control compared with prior periods, even though the company remains unprofitable. Continued expense discipline could extend its operating runway and improve the economics of future commercialization if revenue begins to develop.
Lower Cash Burn
Lower operating cash outflows represent a constructive change in cash discipline and may reduce the pace at which the company consumes resources. This improvement could provide more time to advance its nanorod platform, although it has not yet translated into positive cash generation.
Bears Say
No Revenue Generation
Zero reported revenue shows that the technology has not yet produced a commercial sales base, leaving the business dependent on future product adoption or commercialization arrangements. Without recurring revenue, operating costs remain unsupported and earnings visibility stays structurally weak.
Negative Equity And Shrinking Assets
Negative equity and the sharp reduction in total assets indicate deterioration in balance-sheet strength and reduced financial flexibility. This weak capital position can constrain investment in development and commercialization, while leaving less capacity to absorb continued losses.
Persistent Cash Burn
Persistent negative operating and free cash flow confirms that losses are translating into ongoing cash consumption rather than being offset by operating inflows. Until sales or another durable funding source emerges, continued burn can pressure development plans and financial resilience.
Sona Nanotech Inc News
Sona Nanotech Adds Leading Oncologists to Advisory Board as It Advances Cancer Therapy
Sona Nanotech Inc ( ($TSE:SONA) ) has shared an announcement. Sona Nanotech has strengthened its scientific advisory board with the appointment of two prominent oncologists, melanoma specialist Dr. Michael Smylie
Sona Nanotech Study Supports Tumor-Priming Potential of Targeted Hyperthermia Cancer Therapy
Sona Nanotech Inc ( ($TSE:SONA) ) just unveiled an announcement. Sona Nanotech reported follow-up histology data from its first-in-human early feasibility study of its Targeted Hyperthermia Therapy in advanced melanoma
Sona Nanotech’s Hyperthermia Platform Boosts Immunotherapy Response in Colorectal Cancer Study
An announcement from Sona Nanotech Inc ( ($TSE:SONA) ) is now available. Sona Nanotech reported peer‑reviewed preclinical results showing its Targeted Hyperthermia Therapy, when combined with a standard PD‑1 inhibitor,
Sona Nanotech’s Innovative Approach to Metastatic Melanoma: A Clinical Study Update
Sona Nanotech, Inc (($TSE:SONA)) announced an update on their ongoing clinical study. Sona Nanotech, Inc. is spearheading a clinical study titled ‘Intra-tumoral Targeted Hyperthermic Therapy (THT) for Stage 3C/3D/4M1 Cutaneous
SONA FAQ
What was Sona Nanotech Inc’s price range in the past 12 months?
What is Sona Nanotech Inc’s market cap?
When is Sona Nanotech Inc’s upcoming earnings report date?
How were Sona Nanotech Inc’s earnings last quarter?
Is Sona Nanotech Inc overvalued?
Does Sona Nanotech Inc pay dividends?
What is Sona Nanotech Inc’s EPS estimate?
How many shares outstanding does Sona Nanotech Inc have?
What happened to Sona Nanotech Inc’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Sona Nanotech Inc?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Sona Nanotech Inc
Based in Halifax, Canada, Sona Nanotech Inc. is a life sciences company focused on nanotechnology. It develops and commercializes gold nanorod solutions primarily for diagnostic applications. Their product portfolio includes the Nanotech COVID-19 Lateral Flow Assay, an immunochromatographic test designed to detect the SARS-CoV-2 spike protein antigen in saliva from individuals suspected of having the virus. The company also offers Gemini and Omni gold nanorods, with the latter specifically engineered for medical uses, in addition to providing contract services. These versatile products are utilized in a wide array of applications, such as targeted drug delivery, environmental and food safety monitoring, cellular visualization, cancer therapy, liposuction treatments, and diagnostic tools for medical, consumer, military, and veterinary sectors.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- David Andrew Regan
- Employees
- 8
- Website
- www.sonanano.com
- Address
- Purdy’s Wharf Tower II, Halifax, NS, B3J 3R7, CA
Sona Nanotech Inc (SONA) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 8 | 5 | 9 |
| Technical Analysis | 2 | 5 | 3 |
| Moving Averages | 6 | 0 | 6 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| TSE:BUXBioMark Diagnostics | ||
| TSE:EBMEastwood Bio-Medical Canada | ||
| TSE:SZLS.HStageZero Life Sciences Ltd | ||
| TSE:MIRMedmira | ||
| TSE:ZYUSZYUS Life Sciences |








